← Back to search

Frekil

RWE Generation in minutes

Y CombinatorSpring 2025ActiveHealthcareHealth TechB2BBiotechHealthcare

What they do

Problem

Generating real-world evidence on how drugs perform using fragmented clinical data takes months, delaying safety and efficacy insights.

Solution

Frekil is a platform that connects to clinical data sources (EHR, claims, etc.) and enables end-to-end, auditable RWE studies from design through analysis and reporting in minutes.

Who it's for

Life sciences companies and their clinical/biostatistics and real-world evidence teams use it to run RWE studies on their clinical data.

Founders

Nikhil Tiwari
Co-founder & CEO

Co-founder & CEO at Frekil | IIT Bombay graduate | Prev SWE @ Stripe, Amazon, Marsh&McLennan | Semester Exchange at University of Geneva | Healthcare AI research @ IIT Bombay

Shivesh Gupta
Founder

I’m the co-founder and CTO at Frekil, building AI-powered workflows to generate automated real world evidence of drug performance. Previously, I worked as a systems software engineer at Sony Japan and declined a full-time offer from an HFT to build Frekil. I graduated from IIT Bombay this year, where I also led the institute web and coding club.

Company timeline

Similar startups